Cargando…

GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo

Ex vivo-expanded, allogeneic natural killer (NK) cells can be used for the treatment of various types of cancer. In allogeneic NK cell therapy, NK cells from healthy donors must be expanded in order to obtain a sufficient number of highly purified, activated NK cells. In the present study, we establ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Okjae, Lee, Yuna, Chung, Hyejin, Her, Jung Hyun, Kang, Sang Mi, Jung, Mi-young, Min, Bokyung, Shin, Hyejin, Kim, Tae Min, Heo, Dae Seog, Hwang, Yu Kyeong, Shin, Eui-Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543306/ https://www.ncbi.nlm.nih.gov/pubmed/23326467 http://dx.doi.org/10.1371/journal.pone.0053611

Ejemplares similares

Present and Future of Allogeneic Natural Killer Cell Therapy
por: Lim, Okjae, et al.
Publicado: (2015)

Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy
por: Min, Bokyung, et al.
Publicado: (2018)

Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study
por: Kim, Jong Man, et al.
Publicado: (2021)

Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions
por: Jung, Daun, et al.
Publicado: (2021)

Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability (Running Title: Cryopreserved NK Cells Exhibit Antitumor Effect)
por: Oh, Eonju, et al.
Publicado: (2019)

Erratum: Oh, E., et al. Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability (Running Title: Cryopreserved NK Cells Exhibit Antitumor Effect). Cancers 2019, 11, 966
por: Oh, Eonju, et al.
Publicado: (2020)

Oral Administration of Silk Peptide Enhances the Maturation and Cytolytic Activity of Natural Killer Cells
por: Jang, Sun-Hee, et al.
Publicado: (2018)

GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use
por: Haack-Sørensen, Mandana, et al.
Publicado: (2022)

The Effects of Artemisinin on the Cytolytic Activity of Natural Killer (NK) Cells
por: Houh, Youn Kyung, et al.
Publicado: (2017)

Aurantii Fructus Immaturus enhances natural killer cytolytic activity and anticancer efficacy in vitro and in vivo
por: Park, Arum, et al.
Publicado: (2022)

Harnessing novel engineered feeder cells expressing activating molecules for optimal expansion of NK cells with potent antitumor activity
por: Min, Bokyung, et al.
Publicado: (2021)

Cloned LYT-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo
Publicado: (1984)

Standardized GMP-compliant scalable production of human pancreas organoids
por: Dossena, Marta, et al.
Publicado: (2020)

Discovery of a Potent and Selective JNK3 Inhibitor with Neuroprotective Effect Against Amyloid β-Induced Neurotoxicity in Primary Rat Neurons
por: Jun, Joonhong, et al.
Publicado: (2021)

Disparity in Health Screening and Health Utilization according to Economic Status
por: Kim, Min Jung, et al.
Publicado: (2017)

Human Immunodeficiency Syndromes Affecting Human Natural Killer Cell Cytolytic Activity
por: Ham, Hyoungjun, et al.
Publicado: (2014)

An optimal control approach for enhancing natural killer cells' secretion of cytolytic molecules
por: Makaryan, Sahak Z., et al.
Publicado: (2020)

Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
por: Kogure, Toshiaki, et al.
Publicado: (2003)

Cell-based medicinal products and the development of GMP-compliant processes and manufacturing
por: Romagnoli, Luca, et al.
Publicado: (2011)

Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19
por: Cooper, Rachel S., et al.
Publicado: (2021)

Enhancement of the Anticancer Ability of Natural Killer Cells through Allogeneic Mitochondrial Transfer
por: Kim, Seong-Hoon, et al.
Publicado: (2023)

Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma
por: Choi, Young Bae, et al.
Publicado: (2019)

Allogeneic tumor rejection induced by the intravenous injection of Lyt- 2+ cytolytic T lymphocyte clones
Publicado: (1982)

Stat5b Is Essential for Natural Killer Cell–mediated Proliferation and Cytolytic Activity
por: Imada, Kazunori, et al.
Publicado: (1998)

Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19
por: Osman, Mohammed, et al.
Publicado: (2020)

GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC
por: Fekete, Natalie, et al.
Publicado: (2012)

Automated GMP compliant production of [(18)F]AlF-NOTA-octreotide
por: Tshibangu, Térence, et al.
Publicado: (2020)

Creation of GMP-Compliant iPSCs From Banked Umbilical Cord Blood
por: Tian, Pei, et al.
Publicado: (2022)

Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
por: Lee, Se Jeong, et al.
Publicado: (2015)

In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–Specific Cytolytic T Lymphocytes
por: Speiser, Daniel E., et al.
Publicado: (1999)

Rapid Lytic Granule Convergence to the MTOC in Natural Killer Cells Is Dependent on Dynein But Not Cytolytic Commitment
por: Mentlik, Ashley N., et al.
Publicado: (2010)

Clinical outcomes of prophylactic compression sutures for treatment of uterine atony during the cesarean delivery of twins
por: Kim, Mi-La, et al.
Publicado: (2020)

In Silico Screening and Optimization of Cell-Penetrating Peptides Using Deep Learning Methods
por: Park, Hyejin, et al.
Publicado: (2023)

Fully Automated GMP-Compliant Synthesis of [(18)F]FE-PE2I
por: Bratteby, Klas, et al.
Publicado: (2021)

Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets
por: Fonseca, Alexandra I., et al.
Publicado: (2022)

Allogeneic natural killer cell therapy
por: Berrien-Elliott, Melissa M., et al.
Publicado: (2023)

Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease
por: Shin, Seokwon, et al.
Publicado: (2023)

Development and Testing of an Algorithm to Prevent Medical Device–Related Pressure Injuries
por: Seong, Yeong-Mi, et al.
Publicado: (2021)

Tumour necrosis factor-alpha enhances the cytolytic and cytostatic capacity of interleukin-2 activated killer cells.
por: Matossian-Rogers, A., et al.
Publicado: (1989)

Next generation automated traceless cell chromatography platform for GMP-compliant cell isolation and activation
por: Radisch, Sabine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jmuh0s96pl6ni56istelsp5ub4